Years of design partnership
Distinct asset categories
Brand-consistent output




Novoviah is a Brisbane-based biotechnology company developing the Novoleukin Test System, a platform for measuring antigen-specific T cells in clinical trials. Their work spans pharmaceutical development in celiac disease, autoimmune conditions, and cancer immunotherapy. As the business has grown, so has the range of environments in which they need to show up professionally, from laboratory settings and industry conferences to investor boardrooms and virtual meetings.
When LimeHub established the Novoviah brand identity in a prior engagement, it was designed to work across all of these contexts. But having a brand system is one thing. Having a design partner who can execute it consistently and accurately, across an unusually wide range of physical and digital formats, in a scientifically regulated environment, is another.
Novoviah needed a trusted partner who could work at their pace, understand their technical context, and deliver on-brand materials at short notice without requiring detailed briefing every time.
"Having a brand system is one thing. Having a partner who can execute it accurately across a scientifically regulated environment is another."

Designing for a biotechnology company is different from general marketing design work. Blood vial labels, for instance, are not just brand touchpoints -- they are operational documents used in clinical settings, where accuracy and regulatory compliance carry real weight. Conference materials produced for science forums are reviewed by researchers and clinical professionals who notice when something is imprecise. Investor pitch decks go in front of funding partners who are evaluating scientific credibility alongside commercial potential.
The consistent thread across every format is that the audience holds the materials to a high standard. Design that looks professional but contains an error, or drifts from the brand guidelines, creates a credibility problem that is harder to fix than it is to prevent. The opportunity for LimeHub was to be the team that prevented it -- by staying close to the brand system, understanding the context of each deliverable, and working efficiently enough to turn things around at the pace a growing biotech company requires.
In a scientifically regulated industry, design consistency is not just a brand concern, it is a credibility signal. Every asset LimeHub produces for Novoviah reinforces the same standard of precision that their diagnostics platform is built on.

Designing for a biotechnology company is different from general marketing design work. Blood vial labels, for instance, are not just brand touchpoints -- they are operational documents used in clinical settings, where accuracy and regulatory compliance carry real weight. Conference materials produced for science forums are reviewed by researchers and clinical professionals who notice when something is imprecise. Investor pitch decks go in front of funding partners who are evaluating scientific credibility alongside commercial potential.
The consistent thread across every format is that the audience holds the materials to a high standard. Design that looks professional but contains an error, or drifts from the brand guidelines, creates a credibility problem that is harder to fix than it is to prevent. The opportunity for LimeHub was to be the team that prevented it -- by staying close to the brand system, understanding the context of each deliverable, and working efficiently enough to turn things around at the pace a growing biotech company requires.
With the brand identity established, our role was to be the consistent custodian of it across every new deliverable. Whether producing a pull-up banner for a science forum, a set of blood vial sample labels, or a virtual background for investor video calls, every asset is produced against the same brand guidelines, colour palette, and typographic system. Consistency at this level requires both design discipline and a deep familiarity with how the brand was built -- something that develops through an ongoing relationship, not a one-off project.
Many of Novoviah's design needs sit at the intersection of brand and technical accuracy. Laboratory assets like diagnostic labels need to meet operational requirements as well as brand ones. Conference materials for science forums need to represent the science accurately, not just attractively. We work closely with Novoviah's team to understand the context and constraints of each deliverable, ensuring that what we produce is not only visually consistent but correct.
As Novoviah has grown, the volume and variety of design requests has grown with them. New conference opportunities, new investor conversations, new laboratory environments -- each creates a design need that requires a fast, reliable response. Our working relationship is close enough that briefing is minimal and turnaround is fast. The team knows the brand, knows the context, and knows what Novoviah needs before they have to ask for it.

A relationship that has deepened as Novoviah's portfolio and touchpoints have expanded
Conference materials, laboratory assets, office environments, digital channels, and investor collateral
Every asset produced across every format reflects the same identity system, without exception
The assets LimeHub has produced for Novoviah span blood vial sample labels, custom embroidered lab coats, pull-up banners for science forums and industry conferences, office signage, and virtual meeting backgrounds. Each one reflects the same identity system. Each one meets the standard that Novoviah's audience expects. And each one has been produced with the speed and accuracy that a fast-moving biotech company requires from a design partner who is genuinely embedded in their world.
Schedule a discovery call to discuss your current challenges and explore how a strategic approach can drive growth.